Search Orphan Drug Designations and Approvals
-
Generic Name: | oral testosterone |
---|---|
Date Designated: | 06/02/2016 |
Orphan Designation: | Treatment of constitutional delay of growth and puberty in adolescent boys 14 to 17 years of age. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
TesoRx Pharma, LLC 3670 West Temple Avenue Suite 270 Pomona, California 91768 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-